Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease
Author(s) -
Tomohiro Nakamura,
Chang-ki Oh,
Lujian Liao,
Xu Zhang,
Kevin Lopez,
Daniel Gibbs,
Amanda K. Deal,
Henry Scott,
Brian Spencer,
Eliezer Masliah,
Robert A. Rissman,
John R. Yates,
Stuart A. Lipton
Publication year - 2020
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aaw0843
Subject(s) - s nitrosylation , neuroscience , cyclin dependent kinase 5 , nitric oxide , alzheimer's disease , disease , biology , microbiology and biotechnology , loss function , dynamin , chemistry , enzyme , kinase , biochemistry , medicine , cysteine , receptor , protein kinase a , endocrinology , gene , phenotype , mitogen activated protein kinase kinase , endocytosis
A cascade of NO in Alzheimer's disease One of the ill effects of the amyloid-β peptide that accumulates in Alzheimer's disease (AD) is the promotion of the production of nitric oxide (NO) and consequent nitrosylation of thiols in proteins such as dynamin-related protein 1 (Drp1), which can lead to loss of neuronal synapses. Nakamuraet al. found that this S-nitrosylation occurs in an unusual way. They detected a series of transnitrosylation events in which an NO group is passed between at least three proteins. The deubiquinating enzyme Uch-L1 was S-nitrosylated in brains from human AD patients or in mouse models of AD. Uch-L1 could lead to S-nitrosylation of Drp1 after transferring the NO group to another enzyme, Cdk5 (cyclin-dependent kinase 5). The results implicate a mechanism in which unrelated enzymes might aberrantly function together to disrupt brain function.Science , this issue p.eaaw0843
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom